TRX2 was primarily developed for patients suffering from Androgenic Alopecia (AGA), and so far we have only gathered data for this specific patient group. The results have been very encouraging, especially within patient categories Norwood 1-4.
TRX2 was primarily developed for patients suffering from Androgenic Alopecia (AGA), and so far we have only gathered data for this specific patient group. The results have been very encouraging, especially within patient categories Norwood 1-4.
Comments
0 comments
Please sign in to leave a comment.